Oliver Fetzer insider trades: Arena Pharmaceuticals (ARNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Oliver reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 14, 2019 | ARNA | ↓ Sell | 1,525 | $55.89 | $85K | Direct | Jun 17, 2019 (3d) |
| Dec 3, 2014 | AUXL | ↓ Sell | 100,000 | $34.02 | $3.4M | Direct | Dec 4, 2014 (1d) |
| Aug 15, 2013 | AUXL | ↓ Sell | 1,900 | $18.75 | $36K | Direct | Aug 15, 2013 (0d) |
| Jul 21, 2005 | CBST | ↓ Sell | 3,357 | $17.40 | $58K | Direct | Jul 22, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Oliver Fetzer's insider trades
Oliver Fetzer is a director at Arena Pharmaceuticals (ARNA). Since Jul 21, 2005, Oliver has reported no open-market purchases and 4 sales worth $3.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (43 filings), other transactions (8 filings), option exercises (7 filings), shares returned to the company (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.